Everence Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$519K Buy
9,440
+4,370
+86% +$240K 0.03% 367
2025
Q1
$358K Hold
5,070
0.02% 488
2024
Q4
$333K Buy
+5,070
New +$333K 0.02% 530